Abstract:Exosomes or small extracellular vesicles are considered a new generation of bioinspired-nanoscale drug delivery system (DDS). Endogenous exosomes function as signalosomes since they convey signals via ligands or adhesion molecules located on the exosomal membrane, or packaged inside the exosome. Recently, exosome membrane modification, therapeutic payloads encapsulation, and modulation of in vivo disposition of exosomes have been extensively investigated, among which significant advances have been made to optimize exosome-mediated delivery to solid tumors. Exosomes, specifically tumor cell-derived exosomes, are presumed to have tumor-preferential delivery due to the homotypic features. However, quality attributes that dictate the tissue distribution, cell type-selective uptake, and intracellular payload release of the administered exosomes, as well as the spatiotemporal information regarding exosome fate in vivo, remain to be further investigated. This review summarizes recent advances in developing exosomes as drug delivery platforms with a focus on tumor targeting. The pharmacokinetic features of naive exosomes and factors influencing their intracellular fate are summarized. Recent strategies to improve tumor targeting of exosomes are also reviewed in the context of the biological features of tumor and tumor microenvironment (TME). Selected approaches to augment tumor tissue deposition of exosomes, as well as methods to enhance intracellular payload delivery, are summarized with emphasis on the underlying mechanisms (eg, passive or active targeting, endosomal escape, etc.). In conclusion, this review highlights recently reported tumor-targeting strategies of exosome-based drug delivery, and it's in the hope that multiple approaches might be employed in a synergistic combination in the development of exosome-based cancer therapy.

Subcellular drug distribution: mechanisms and roles in drug efficacy, toxicity, resistance, and targeted delivery

Subcellular Drug Distribution: Exploring Organelle-Specific Characteristics for Enhanced Therapeutic Efficacy

Subcellular Visualization: Organelle-Specific Targeted Drug Delivery and Discovery

Living Cell for Drug Delivery

Research progress in toxic effects of antitumor drugs based on drug transporter

Transporting Carriers for Intracellular Targeting Delivery Via Non-Endocytic Uptake Pathways

Emerging Magic Bullet: Subcellular Organelle-Targeted Cancer Therapy

Subcellular targeting strategies for protein and peptide delivery

The Physiological Role of Drug Transporters

Nanocarriers address intracellular barriers for efficient drug delivery, overcoming drug resistance, subcellular targeting and controlled release

Transporter-Guided Delivery of Nanoparticles to Improve Drug Permeation across Cellular Barriers and Drug Exposure to Selective Cell Types

Research and Development of Drug Delivery Systems Based on Drug Transporter and Nano-Formulation

Beyond Nanoparticle‐based Intracellular Drug Delivery: Cytosol/Organelle‐Targeted Drug Release and Therapeutic Synergism

In vivo Fate of Targeted Drug Delivery Carriers

Tailoring nanoparticles for targeted drug delivery: From organ to subcellular level

Multifunctional nanoplatforms for subcellular delivery of drugs in cancer therapy

In Response to Precision Medicine: Current Subcellular Targeting Strategies for Cancer Therapy

Organelle Targeted Drug Delivery: Key Challenges, Recent Advancements and Therapeutic Implications

Advances in Exosome-Based Drug Delivery and Tumor Targeting: From Tissue Distribution to Intracellular Fate

Cell-based Drug Delivery Systems and Their in Vivo Fate.

Recent Development of Drug Delivery Systems through Microfluidics: From Synthesis to Evaluation